Life Stem Genetics (LIFS) Stock Price

Life Stem Genetics Price

OTC·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

The stock trades about 200% above its 52-week low.

Life Stem Genetics stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Life Stem Genetics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Life Stem Genetics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Life Stem Genetics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Life Stem Genetics Stock Price History
DateLife Stem Genetics Price
8/14/20260.00 USD
8/13/20260.00 USD
8/12/20260.00 USD
8/11/20260.00 USD
8/10/20260.00 USD
8/7/20260.00 USD
8/6/20260.00 USD
8/5/20260.00 USD
8/4/20260.00 USD
8/3/20260.00 USD
7/30/20260.00 USD
7/29/20260.00 USD
7/28/20260.00 USD
7/27/20260.00 USD
7/24/20260.00 USD
7/23/20260.00 USD
7/22/20260.00 USD
7/21/20260.00 USD
7/20/20260.00 USD
7/17/20260.00 USD
7/16/20260.00 USD
7/15/20260.00 USD
7/14/20260.00 USD
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/3/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/19/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
4/22/20260.00 USD
4/21/20260.00 USD
4/20/20260.00 USD
4/17/20260.00 USD
4/16/20260.00 USD
4/15/20260.00 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
Access this data via the Eulerpool API
Get Free API Key

Life Stem Genetics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2012
0.00 USD
-38,762.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
-38,762.00 USD
-38,762.00 USD
Jan 1, 2024
0.00 USD
-40,782.00 USD
-40,782.00 USD
Jan 1, 2025
0.00 USD
-10,540.00 USD
-10,572.00 USD

Life Stem Genetics Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 17, 2026, 4:34 PM
 
SHARESM
2012201320242025
52.0028.53245.84245.84
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Life Stem Genetics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Life Stem Genetics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Life Stem Genetics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Life Stem Genetics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Life Stem Genetics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Life Stem Genetics stock margins

The Life Stem Genetics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Life Stem Genetics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Life Stem Genetics.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2012
0.00 %
- %
0.00 %
Jan 1, 2013
0.00 %
- %
- %
Jan 1, 2024
0.00 %
- %
- %
Jan 1, 2025
0.00 %
- %
- %

Life Stem Genetics Stock Revenue, EBIT, Earnings per Share

The Life Stem Genetics earnings per share therefore indicates how much revenue Life Stem Genetics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2012
0.00 USD
-0.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
-0.00 USD
-0.00 USD
Jan 1, 2024
0.00 USD
-0.00 USD
-0.00 USD
Jan 1, 2025
0.00 USD
-0.00 USD
-0.00 USD

Life Stem Genetics business model & stock analysis

Life Stem Genetics Inc is a company specializing in regenerative medicine, specifically in the manufacturing and application of stem cell therapies. It was founded in 2012 by experienced scientists and entrepreneurs and has since become a leading provider of stem cell treatments. The business model of Life Stem Genetics is based on the development and application of stem cell therapies that aim to regenerate diseased or injured tissues and organs. These therapies are utilized by specialized doctors and clinics worldwide to treat a variety of conditions and injuries, including degenerative diseases such as arthritis, osteoporosis, and Alzheimer's, as well as joint, muscle, and bone injuries. The company operates in various sectors, each focusing on different aspects of regenerative medicine. One of these sectors is the research of new stem cell therapies and technologies, aiming to improve the effectiveness and efficiency of treatments. This includes the identification of new types of stem cells, the development of new cultivation techniques, and the optimization of procedures for stem cell transplantation. Another sector of Life Stem Genetics is the production of stem cell products that can be used by doctors and clinics for patient treatment. This includes stem cell preparations for injection into the bloodstream or tissues, as well as freeze & thaw preparations used for long-term storage of stem cells. In addition to research and production of stem cell therapies, Life Stem Genetics also offers consulting services for doctors and clinics interested in utilizing stem cell treatments. This includes training and workshops on stem cell therapy, support in setting up stem cell clinics, and expert opinions on specific application areas. The products of Life Stem Genetics include various stem cell therapies tailored to the treatment of specific diseases and injuries. For example, the company offers stem cell therapies for the treatment of arthritis, spinal injuries, and diabetes. Furthermore, the company has also developed stem cell treatments specifically targeting the regeneration of skin tissue and hair follicles. Overall, Life Stem Genetics is an innovative company in the field of regenerative medicine, contributing to the improvement of patients' lives worldwide through its research, production, and application of stem cell therapies. With its diverse product portfolio and extensive expertise in the selection and use of stem cells, the company is a significant player in this field and will continue to play an important role in the development of new therapies and treatment options in the future.

Life Stem Genetics SWOT Analysis

Strengths

Life Stem Genetics Inc possesses several strengths that contribute to its competitive advantage in the market:

  • Strong research and development capabilities, allowing for continual advancement in stem cell technology and therapies.
  • Robust intellectual property portfolio, providing protection and opportunities for commercialization.
  • Established network of strategic partnerships with leading healthcare institutions and academic organizations.
  • Experienced and knowledgeable team of scientists, physicians, and researchers.
  • Highly reputable brand image, built on cutting-edge innovation and ethical practices.

Weaknesses

Despite its strengths, Life Stem Genetics Inc is faced with certain weaknesses that may hinder its growth and performance:

  • Limited market presence and customer base, resulting in reduced brand recognition.
  • Relatively high production costs, potentially impacting pricing and profitability.
  • Dependence on external funding sources for research and development projects.
  • Regulatory complexities and strict compliance requirements in the field of stem cell research.
  • Competition from larger, more established companies with greater resources.

Opportunities

Life Stem Genetics Inc can leverage the following opportunities to enhance its market position and drive growth:

  • Growing global demand for regenerative medicine and stem cell-based therapies.
  • Expansion into emerging markets with untapped potential, such as Asia Pacific and Latin America.
  • Collaboration opportunities with pharmaceutical companies for joint research and product development.
  • Advancements in technology and techniques, enabling more efficient and scalable manufacturing processes.

Threats

Life Stem Genetics Inc should be cautious of the following threats that may pose challenges to its success:

  • Stringent regulatory environment, requiring compliance with complex legal and ethical standards.
  • Potential negative public perception or controversies surrounding stem cell research.
  • Rapidly evolving competitive landscape, with increasing competition from both established and emerging players.
  • Economic instability or financial constraints impacting healthcare spending and investments.

Life Stem Genetics Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Life Stem Genetics historical P/E ratio, EBIT multiple, and P/S ratio

Life Stem Genetics annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Life Stem Genetics shares outstanding

The number of shares of Life Stem Genetics was 245.84 M in 2025. This indicates how many shares Life Stem Genetics is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2012
52.00 M Stocks
Jan 1, 2013
28.53 M Stocks
Jan 1, 2024
245.84 M Stocks
Jan 1, 2025
245.84 M Stocks

Life Stem Genetics stock splits

In Life Stem Genetics's history, there have been no stock splits.
Price targets and forecasts for Life Stem Genetics are not yet available.

Life Stem Genetics Executives and Management Board

3 members · avg. age 41 · 67 % women

Management

GS

Gloria Simov (27)

President, Chief Executive Officer, Director · since 2013

–
HS

Heather Sharp (41)

Chief Financial Officer, Director · since 2013

–

Board of Directors

VP

Dr. Vino Padayachee (54)

Chairman of the Board · since 2014

–

Frequently asked questions about Life Stem Genetics

The business model of Life Stem Genetics Inc revolves around providing innovative stem cell therapies and regenerative medicine solutions. As a leading biotechnology company, Life Stem Genetics Inc focuses on researching and developing groundbreaking treatment options utilizing the potential of stem cells in various medical applications. Their extensive portfolio includes cutting-edge advancements in stem cell therapy, tissue engineering, and personalized medicine. By leveraging collaboration with medical professionals, academic institutions, and industry leaders, Life Stem Genetics Inc aims to revolutionize healthcare and improve patients' quality of life through their pioneering regenerative therapies.

Life Stem Genetics Inc is primarily active in the biotechnology industry.

The main competitors of Life Stem Genetics Inc in the market include companies such as Regenexx, Celularity, and Osiris Therapeutics.

Life Stem Genetics Inc is a renowned biotechnology company focused on harnessing the potential of stem cells for regenerative medicine. Founded in 2008, the company has made significant contributions to the field, pioneering groundbreaking research and development. Life Stem Genetics Inc has a strong emphasis on precision medicine and personalized therapies, aiming to revolutionize healthcare by offering innovative treatments for a range of conditions. With its cutting-edge technologies and world-class team of scientists, Life Stem Genetics Inc has earned a reputation for its commitment to improving patient outcomes and advancing the field of regenerative medicine.

Life Stem Genetics Inc has achieved several significant milestones in its journey. The company has successfully developed cutting-edge stem cell therapies that have shown promising results in treating various diseases and conditions. Life Stem Genetics Inc has also established strategic collaborations with renowned research institutions and pharmaceutical companies to accelerate the development and commercialization of its innovative therapies. Furthermore, the company has obtained regulatory approvals for its therapies, allowing them to be accessible to patients in need. With its commitment to revolutionizing healthcare through stem cell technology, Life Stem Genetics Inc is continuously striving to achieve new milestones and transform the lives of individuals worldwide.

Life Stem Genetics Inc is primarily present in several countries and regions. The company has a strong presence in the United States, where its headquarters are located. Additionally, Life Stem Genetics Inc has extended its operations to various regions, including Europe, Asia, and South America. With its global reach, the company aims to provide innovative stem cell therapies and solutions in partnership with leading healthcare institutions worldwide.

Life Stem Genetics Inc represents values such as innovation, excellence, and integrity. The company is committed to providing cutting-edge solutions in the field of stem cell research and genetics. With a focus on scientific advancements, Life Stem Genetics Inc aims to revolutionize healthcare by offering personalized therapies and diagnostics. By embracing ethical practices and maintaining high standards, the company strives to foster trust and credibility among its stakeholders. Life Stem Genetics Inc prioritizes patient well-being and continually enhances its offerings to contribute positively to the healthcare industry's growth and development.

Converted at the current exchange rate, the Life Stem Genetics share trades at 0.00 EUR (0.00 USD).

Life Stem Genetics Inc is a leading company in the field of precision medicine and personalized healthcare. They focus on stem cell technologies and genome sequencing. The company aims to utilize the potential of stem cells in the diagnosis, therapy, and prevention of diseases through innovative technologies and methods. The core business of Life Stem Genetics Inc focuses on three main areas: 1. Diagnosis of hereditary diseases: By combining genome sequencing and stem cell technology, the company is able to diagnose hereditary diseases early and develop individualized therapy concepts. 2. Therapeutic application of stem cells: Life Stem Genetics Inc utilizes the potential of stem cells for the development of cell-based therapeutics and regenerative therapy approaches. This involves replacing defective cells in the body or repairing damaged tissues. 3. Disease prevention: By genetically analyzing individuals, Life Stem Genetics Inc can determine the individual risk for certain diseases. In combination with lifestyle and nutrition strategies, customers can actively prevent specific illnesses. The products of Life Stem Genetics Inc include diagnostic tests for identifying hereditary diseases such as hereditary cancers or neurodegenerative diseases. The company also offers stem cell-based therapy approaches that are currently being studied in various clinical trials. Additionally, Life Stem Genetics Inc provides genetic counseling services to support customers in implementing prevention strategies. A major focus of Life Stem Genetics Inc is on research and development of new therapy approaches. This involves developing innovative stem cell technologies and testing them in clinical trials. The goal is to find new ways to treat diseases that were previously considered incurable. The business model of Life Stem Genetics Inc is designed for long-term sustainability. The company aims to offer its customers holistic healthcare based on their personal needs and circumstances. A strong emphasis is placed on research and development of new technologies to continuously improve the effectiveness of diagnostic and therapeutic concepts. In summary, Life Stem Genetics Inc is an innovative company in the field of precision medicine and personalized healthcare. They utilize stem cell technologies and genome sequencing to develop tailored diagnostic, therapeutic, and prevention concepts for their customers. Through comprehensive research efforts, Life Stem Genetics Inc aims to find new therapy approaches for previously incurable diseases and thus improve healthcare in the long term.

The revenue cannot currently be calculated for Life Stem Genetics.

The profit cannot currently be calculated for Life Stem Genetics.

The P/E ratio cannot be calculated for Life Stem Genetics at the moment.

The P/S cannot be calculated for Life Stem Genetics currently.

The Eulerpool Quality Score for Life Stem Genetics is 2/10.

The ISIN of Life Stem Genetics is US53217Y1038. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Life Stem Genetics is LIFS. The ticker symbol is used to trade Life Stem Genetics shares on the stock exchange.

Life Stem Genetics paid dividends every year for the past 0 years.

Life Stem Genetics is assigned to the '—' sector.

The dividends of Life Stem Genetics are distributed in USD.

All fundamentals and in-depth analysis of Life Stem Genetics

Our stock analysis for Life Stem Genetics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Life Stem Genetics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Life Stem Genetics Stock
Life Stem Genetics Revenue→
Life Stem Genetics Stock
Life Stem Genetics Net Income→
Life Stem Genetics Stock
Life Stem Genetics P/E→
Life Stem Genetics Stock
Life Stem Genetics P/S→
Life Stem Genetics Stock
Life Stem Genetics EBIT→
Life Stem Genetics Stock
Life Stem Genetics Dividend→
Life Stem Genetics Stock
Life Stem Genetics Directors Dealings→
Life Stem Genetics Stock
Life Stem Genetics Stocks→
Life Stem Genetics Stock
Life Stem Genetics Market capitalization→
Life Stem Genetics Stock
Life Stem Genetics Debt→
Life Stem Genetics Stock
Life Stem Genetics Liabilities→
Life Stem Genetics Stock
Life Stem Genetics Equity→
Life Stem Genetics Stock
Life Stem Genetics AAQS→
Life Stem Genetics Stock
Life Stem Genetics Employees→
Life Stem Genetics Stock
Life Stem Genetics ROE→
Life Stem Genetics Stock
Life Stem Genetics ROA→
Life Stem Genetics Stock
Life Stem Genetics ROCE→
Life Stem Genetics Stock
Life Stem Genetics News→
Life Stem Genetics Stock
Life Stem Genetics Analyst Price Targets→

— Stocks

Light AILibo PharmaLight Science Technologies HoldingsLibero football financeLightelLianlian DigiTech CoLikhami ConsultingLi-FT PowerLima Dua Lima Tiga PT TbkLG CNS CoLiminatus PharmaLFNT ResourcesAll Stocks A–Z →